Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Follicular 1 Arthritis, Rheumatoid 1

Interventions

Methotrexate 4 veltuzumab 1 tocilizumab 1 andecaliximab 1 Tumor Necrosis Factor Inhibitors 1 RC-18 1 Nivolumab 1 Interleukin 1 Receptor Antagonist Protein 1 Folic Acid 1 Etanercept 1 Bortezomib 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Arthritis, Rheumatoid × veltuzumab × Clear all

NCT01390545 2016-04-13

VELVET

Takeda

Phase 2 Terminated

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡